Pay in 4 interest-free payments of $5.92 Learn more
Ships within 48 hours · Estimated delivery Oct 26 - Oct 31
Foundayo is expected to be a once-daily tablet with a more flexible routine than oral semaglutide
Always report persistent symptoms to your PlexusDx prescriber
Using a microsimulation model based primarily on the UK Prospective Diabetes Study Outcomes Model 2 equations, the lifetime cost-effectiveness of oral semaglutide added to the current antihyperglycemic treatment for T2DM in the US showed that oral semaglutide was more cost-effective compared with liraglutide and had incremental cost-effectiveness ratios between $100,000 and $150,000 per QALY versus sitagliptin and background therapy alone
Risk Factors, Screening and the Role of Prophylactic Oophorectomy
IGF-1 LR3 Regulatory Status United States (as of June 2026)
US$ 25.97
US$ 28.33
US$ 24.55
US$ 25.50
US$ 20.67
US$ 27.50
US$ 27.73
US$ 25.96
US$ 21.64
